Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 20,278 shares at $13.37 ($271K) on 2025-06-18, disclosed to the SEC on 2025-06-20.
Scheduled sale ($271k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.37 | 10,139 | $136K | 50.0% |
| 2 | $13.37 | 10,139 | $136K | 50.0% |
| Total | $13.37 avg | 20,278 | $271K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |